Peter Nigrovic
Rheumatology · Boston, MANPI 1154388528
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,589 of the $74,648 with a category attached, or 62.4%. 10 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 29.5% of the total. Reporting peaked in 2019 at $20,984 and has fallen 79.8% since, to $4,245 in 2024. Among rheumatology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $1588.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$22K
- Swedish Orphan Biovitrum AB$16K
- Pfizer$15K
- Novartis$12K
- Alkermes, Inc.$4K
- Qiagen, LLC$3K
- plus $4K from 4 others
Across 13 payments — averaging $113,008 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$915K
- Pfizer$416K
- Novartis$137K
What the payments were for
- Consulting fees$46,58962%
- Speaking & faculty fees$15,52521%
- Travel & lodging$11,73516%
- Food & beverage$7801%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 15 | $22,055 |
| Swedish Orphan Biovitrum AB | 5 | $15,771 |
| Pfizer | 7 | $14,777 |
| Novartis | 11 | $11,603 |
| Alkermes, Inc. | 1 | $3,600 |
| Qiagen, LLC | 1 | $3,199 |
| Miach Orthopaedics, Inc. | 1 | $1,800 |
| Merck | 4 | $1,699 |
| Gilead | 1 | $125 |
| Sobi, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$74,648 in reported general payments places this provider in the 90th percentile of 265 rheumatology providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $306 |
| Oxycodone Hcl | 14 | $56 |
| Tramadol Hcl | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Boston
- Marilyn PikeBoston$1.4M
- John StoneBoston$926K
- Lee SimonBoston$600K
- Jeffrey SparksBoston$299K
- Tanya LaidlawBoston$244K
- Tuhina NeogiBoston$242K
- Michael WeinblattBoston$228K
- Michael BrennerBoston$115K
- Zachary WallaceBoston$106K
- Flavia CastelinoBoston$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.